Cite
HARVARD Citation
Mai, E. et al. (2016). Single versus tandem high‐dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long‐term results from the phase III GMMG‐HD2 trial. British journal of haematology. pp. 731-741. [Online].